Obesity is associated with brain’s neurotransmitters
News Mar 04, 2015
Researchers at Aalto University and University of Turku have revealed how obesity is associated with altered opioid neurotransmission in the brain.
New research reveals how obesity is associated with altered functioning of brain’s opioid system, which is intimately involved in generating pleasurable sensations. Researchers found that obesity was associated with significantly lowered number of opioid receptors in the brain. However, no changes were observed in the dopamine neurotransmitter system, which regulates motivational aspects of eating.
Obesity is a great challenge to human health worldwide because it is associated with serious medical conditions such as type 2 diabetes, coronary heart disease, and stroke. Even though it is well known that unhealthy eating habits are the major cause for obesity, people have often problems with restraining their eating.
The findings, published in The Journal of Neuroscience, highlight how obesity is associated with brain-level molecular changes. It is possible that the lack of brain’s opioid receptors predisposes the obese individuals to overeating to compensate decreased hedonic responses in this system, say professor Lauri Nummenmaa and researcher Henry Karlsson.
The findings have major implications for understanding the causes of obesity and the mechanisms involved in overeating, and provide insight into behavioral and pharmacological treatment and prevention of obesity. However, it is not yet known whether the altered brain neurochemistry is a cause or consequence of obesity.
The researchers measured availability of mu-opioid and type 2 dopamine receptors in normal-weight and obese individuals’ brains using positron emission tomography at the Turku PET Centre.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Henry K. Karlsson, Lauri Tuominen, Jetro J. Tuulari, Jussi Hirvonen, Riitta Parkkola, Semi Helin, Paulina Salminen, Pirjo Nuutila, Lauri Nummenmaa. Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain. The Journal of Neuroscience, Published March 4 2015. doi: 10.1523/JNEUROSCI.4744-14.2015
Researchers Find a Way to Separate Side Effects of Opioid Drugs Reducing RiskNews
Scientists have discovered a way to separate these two effects -- pain relief and breathing, opening a window of opportunity to make effective pain medications without the risk of respiratory failure.READ MORE
Biological Mechanism of a Leading Cause of Childhood Blindness RevealedNews
Scientists have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.READ MORE
Machine Learning: Helping Determine How a Drug Affects the BrainNews
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published today in Brain.READ MORE